Director, Regulatory Policy & External Relations
Mr Keravich has 30 years of pharmaceutical R&D experience, including leadership roles with regulatory responsibilities at NIH, FDA and GSK Consumer Healthcare. Currently, he is the GSK Regulatory Director and Lead for the US Monograph Reform. Other GSK Consumer Healthcare experiences include:.
• Director for Regulatory Affairs and Regulatory Policy at GSK Consumer Healthcare
• Director, US OTC Switch and Regulatory Policy, Global Regulatory Affairs at GSK. OTC switches included Voltaren, Flonase, Veramyst and Alli.
• US Regulatory Affairs lead for the Wellness Category
• Four years of FDA experience serving a co-team leader, reviewer and Project Manager within the Division of Nonprescription Drug Products
Prior to his service at FDA, Mr Keravich has also served for ten years at the National Institutes of Health. Pharmacy Section Chief with responsibilities that focused on the design, coordination and execution of phase II and phase III clinical trials He had clinical pharmacy responsibilities for NIDDK intramural research programs and provided regulatory submission assistance for the institutes and an IRB member for the National Institute of Aging.
Lastly, Mr Keravch has worked as a hospital clinical pharmacist, retail pharmacist and home heallth care pharmacist early in his career.
Wednesday, September 16, 2020
12:05 PM – 1:00 PM EDT